PURPOSE: To examine the general health status and health-related quality of life (HRQOL) along the diabetes continuum of middle-aged and older Finns, and to determine the glucose metabolism stage by which the HRQOL has decreased noticeably. METHODS: The cross-sectional sample consisted of 920 persons aged 51-75 from the general population in a single municipality in a rural area of Eastern Finland. Data were adjusted for age, sex, smoking history, current alcohol consumption, employment and marital status. The HRQOL and health status were evaluated using two preference-based HRQOL instruments, 15D and SF-6D, and one health profile instrument, 36-Item Short Form Health Survey (SF-36). RESULTS: Individuals with impaired glucose tolerance (IGT) and type 2 diabetes had noticeably low mean SF-6D, 15D and general health status. The decrease in overall HRQOL was mainly due to a decline in the physical dimensions of HRQOL. The adjusted odds ratios (95% CI) for having noticeably low HRQOL on SF-6D, 15D and general health dimension of SF-36 associated with IGT were 1.95 (1.18-3.25), 1.35 (0.84-2.18) and 2.00 (1.21-3.29), respectively. CONCLUSIONS: The progression along the diabetes continuum was significantly associated with a decrease in HRQOL and health status. Furthermore, the data indicate that when a person is detected to have IGT, the HRQOL and general health status have already diminished noticeably. The prevailing evidence suggests that detection and intervention before a patient develops IGT is essential in order to minimize the loss of quality of life and quality-adjusted life years.
PURPOSE: To examine the general health status and health-related quality of life (HRQOL) along the diabetes continuum of middle-aged and older Finns, and to determine the glucose metabolism stage by which the HRQOL has decreased noticeably. METHODS: The cross-sectional sample consisted of 920 persons aged 51-75 from the general population in a single municipality in a rural area of Eastern Finland. Data were adjusted for age, sex, smoking history, current alcohol consumption, employment and marital status. The HRQOL and health status were evaluated using two preference-based HRQOL instruments, 15D and SF-6D, and one health profile instrument, 36-Item Short Form Health Survey (SF-36). RESULTS: Individuals with impaired glucose tolerance (IGT) and type 2 diabetes had noticeably low mean SF-6D, 15D and general health status. The decrease in overall HRQOL was mainly due to a decline in the physical dimensions of HRQOL. The adjusted odds ratios (95% CI) for having noticeably low HRQOL on SF-6D, 15D and general health dimension of SF-36 associated with IGT were 1.95 (1.18-3.25), 1.35 (0.84-2.18) and 2.00 (1.21-3.29), respectively. CONCLUSIONS: The progression along the diabetes continuum was significantly associated with a decrease in HRQOL and health status. Furthermore, the data indicate that when a person is detected to have IGT, the HRQOL and general health status have already diminished noticeably. The prevailing evidence suggests that detection and intervention before a patient develops IGT is essential in order to minimize the loss of quality of life and quality-adjusted life years.
Authors: Daria J O'Reilly; Feng Xie; Eleanor Pullenayegum; Hertzel C Gerstein; Janet Greb; Gord K Blackhouse; Jean-Eric Tarride; Jim Bowen; Ron A Goeree Journal: Qual Life Res Date: 2011-01-08 Impact factor: 4.147
Authors: Ravishankar Jayadevappa; Stanley Bruce Malkowicz; Marsha Wittink; Alan J Wein; Sumedha Chhatre Journal: Health Serv Res Date: 2012-03-14 Impact factor: 3.402
Authors: Robyn J Tapp; David W Dunstan; Pat Phillips; Andrew Tonkin; Paul Z Zimmet; Jonathan E Shaw Journal: Diabetes Res Clin Pract Date: 2006-06-05 Impact factor: 5.602
Authors: J Lindström; M Peltonen; J G Eriksson; P Ilanne-Parikka; S Aunola; S Keinänen-Kiukaanniemi; M Uusitupa; J Tuomilehto Journal: Diabetologia Date: 2012-10-24 Impact factor: 10.122
Authors: Tellervo Seppälä; Ulla Saxen; Hannu Kautiainen; Salme Järvenpää; Päivi E Korhonen Journal: Prim Care Diabetes Date: 2013-04-29 Impact factor: 2.459
Authors: Emily D Williams; Lal Rawal; Brian F Oldenburg; Carla Renwick; Jonathan E Shaw; Robyn J Tapp Journal: Diabetes Care Date: 2012-03-23 Impact factor: 19.112
Authors: Anne Neumann; Olaf Schoffer; Fredrik Norström; Margareta Norberg; Stefanie J Klug; Lars Lindholm Journal: Health Qual Life Outcomes Date: 2014-10-24 Impact factor: 3.186
Authors: Laura J Scott; Michael R Erdos; Jeroen R Huyghe; Ryan P Welch; Andrew T Beck; Brooke N Wolford; Peter S Chines; John P Didion; Narisu Narisu; Heather M Stringham; D Leland Taylor; Anne U Jackson; Swarooparani Vadlamudi; Lori L Bonnycastle; Leena Kinnunen; Jouko Saramies; Jouko Sundvall; Ricardo D'Oliveira Albanus; Anna Kiseleva; John Hensley; Gregory E Crawford; Hui Jiang; Xiaoquan Wen; Richard M Watanabe; Timo A Lakka; Karen L Mohlke; Markku Laakso; Jaakko Tuomilehto; Heikki A Koistinen; Michael Boehnke; Francis S Collins; Stephen C J Parker Journal: Nat Commun Date: 2016-06-29 Impact factor: 14.919
Authors: Luli S Zou; Michael R Erdos; D Leland Taylor; Peter S Chines; Arushi Varshney; Stephen C J Parker; Francis S Collins; John P Didion Journal: BMC Genomics Date: 2018-05-23 Impact factor: 3.969
Authors: Saku Väätäinen; Henna Cederberg; Risto Roine; Sirkka Keinänen-Kiukaanniemi; Jouko Saramies; Hannu Uusitalo; Jaakko Tuomilehto; Janne Martikainen Journal: PLoS One Date: 2016-02-03 Impact factor: 3.240